Non-hepatic, probably non-CYP metabolism.

(To be edited, initial data ST OCT 04) Sodium mercaptethane sulfonate administered during treatment with iophosphamide in order to counteract urinary tract toxicity caused by acroleine formed. Converted to free thiol in serum and eliminated in urine.